Systematic comparative protein expression profiling of clear cell renal cell carcinoma: A pilot study based on the separation of tissue specimens by two-dimensional gel electrophoresis

Molecular and Cellular Proteomics

Volumn 8, Issue 12, 2009, Pages 2827-2842

  Lichtenfels, Rudolf ^a   Dressler, Sven P ^a   Zobawa, Monica ^b   Recktenwald, Christian V ^a   Ackermann, Angelika ^c   Atkins, Derek ^d   Kersten, Michael ^e   Hesse, Andrea ^a   Puttkammer, Maria ^a   Lottspeich, Friedrich ^b   Seliger, Barbara ^a  

^a MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

^b MAX PLANCK INSTITUTE OF BIOCHEMISTRY   (Germany)

^c JOHANNES GUTENBERG UNIVERSITY   (Germany)

^d UNIVERSITY OF WITTEN HERDECKE   (Germany)

^e Toplab GmbH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CALBINDIN; FATTY ACID BINDING PROTEIN; GELSOLIN;

ARTICLE; CLEAR CELL CARCINOMA; CLINICAL ARTICLE; COMPARATIVE STUDY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KIDNEY CARCINOMA; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; TISSUE MICROARRAY; TWO DIMENSIONAL ELECTROPHORESIS;

CALCIUM-BINDING PROTEIN, VITAMIN D-DEPENDENT; CARCINOMA, RENAL CELL; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; EPITHELIUM; FATTY ACID-BINDING PROTEINS; GELSOLIN; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; KIDNEY NEOPLASMS; NEOPLASM PROTEINS; PILOT PROJECTS; PROTEOMICS; REPRODUCIBILITY OF RESULTS; TISSUE ARRAY ANALYSIS;

EID: 75149191853     PISSN: 15359476     EISSN: None     Source Type: Journal    
DOI: 10.1074/mcp.M900168-MCP200     Document Type: Article

References (53)

1. Drucker, B. J. (2005) Renal cell carcinoma: current Status and future prospects. Cancer Treat. Rev. 31, 536-545
2. Pantuck, A. J., Zisman, A., and Belldegrun, A. S. (2001) The changing natural history of renal cell carcinoma. J. Urol. 166, 1611-1623
3. Yang, J. C., and Childs, R. (2006) Immunotherapy for renal cell cancer. J. Clin. Oncol. 24, 5576-5583
4. Kerst, J. M., Bex. A., Mallo, H., Dewit, L., Haanen, J. B., Boogerd, W., Teertstra, H. J., and de Gast, G. C. (2005) Prolonged low dose IL-2 and thalidomide in progressive metastatic renal cell carcinoma with concurrent radiotherapy to bone and/or soft tissue metastasis: a phase II study. Cancer Immunol. Immunother. 54, 926-931
5. Motzer, R. J., and Bukowski, R. M. (2006) Targeted therapy for metastatic renal cell carcinoma. J. Clin. Oncol. 24, 5601-5608
6. Longo, R., D'Andrea, M. R., Sarmiento, R., Salerno, F., and Gasparini, G. (2007) Integrated therapy of kidney cancer. Ann. Oncol. 18, Suppl. 6, vi141-vi148
7. Rini, B. I. (2007) Vascular endothelial growth factor-targeted therapy in renal cell carcinoma: current status and future directions. Clin. Cancer Res. 13, 1098-1106
8. Tan, M. H., Rogers, C. G., Cooper, J. T., Ditlev, J. A., Maatman, T. J., Yang, X., Furge, K. A., and Teh, B. T. (2004) Gene expression profiling of renal cell carcinoma. Clin. Cancer Res. 10, 6315S-6321S
9. Yang, X. J., Sugimura, J., Schafernak, K. T., Tretiakova, M. S., Han, M., Vogelzang, N. J., Furge, K., and Teh, B. T. (2006) Classification of renal neoplasms based on molecular signatures. J. Urol. 175, 2302-2306
10. Wang, E., Lichtenfels, R., Bükur, J., Ngalame, Y., Panelli, M. C., Seliger, B., and Marincola, F. M. (2004) Ontogeny and oncogenesis balance the transcriptional profile of renal cell cancer. Cancer Res. 64, 7279-7287
11. Higgins, J. P., Shinghal, R., Gill, H., Reese, J. H., Terris, M., Cohen, R. J., Fera, M., Pollack, J. R., van de Rijn, M., and Brooks, J. D. (2003) Gene expression patterns in renal cell carcinoma assessed by complementary DMA microarray. Am. J. Pathol. 162, 925-932
12. Young, A. N., Amin, M. B., Moreno, C. S., Lim, S. D., Cohen, C., Petros, J. A., Marshall, F. F., and Neish, A. S. (2001) Expression profiling of renal epithelial neoplasms: a method for tumor classification and discovery of diagnostic molecular markers. Am. J. Pathol. 158, 1639-1651
13. Yamazaki, K., Sakamoto, M., Ohta, T., Kanai, Y., Ohki, M., and Hirohashi, S. (2003) Overexpression of KIT in chromophobe renal cell carcinoma. Oncogene 22, 847-852
14. Takahashi, M., Yang, X. J., Sugimura, J., Backdahl, J., Tretiakova, M., Qian, C. N., Gray, S. G., Knapp, R., Anema, J., Kahnoski, R., Nicol, D., Vogelzang, N. J., Furge, K. A., Kanayama, H., Kagawa, S., and Teh, B. T. (2003) Molecular subclassification of kidney tumors and the discovery of new diagnostic markers. Oncogene 22, 6810-6818
15. Perroud, B., Lee, J., Valkova, N., Dhirapong, A., Lin, P. Y., Fiehn, O., Kültz, D., and Weiss, R. H. (2006) Pathway analysis of kidney cancer using proteomics and metabolic profiling. Mol. Cancer 5, 64
16. Seliger, B., Lichtenfels, R., and Kellner, R. (2003) Detection of renal cell carcinoma-associated markers via proteome- and other 'ome'-based analyses. Brief. Funct. Genomics Proteomics 2, 194-212
17. Seliger, B., Dressler, S. P., Lichtenfels, R., and Kellner, R. (2007) Candidate biomarkers in renal cell carcinoma. Proteomics 7, 4601-4612
18. Banks, R. E., Craven, R. A., Hamden, P., Madaan, S., Joyce, A., and Selby, P. J. (2007) Key clinical issues in renal cancer a challenge for proteomics. World J. Urol. 25, 537-556
19. Craven, R. A., and Banks, R. E. (2008) Understanding and managing renal cell carcinoma: can proteomic studies contribute to clinical practice? Contrib. Nephrol. 160, 88-106
20. Okamura, N., Masuda, T., Gotoh, A., Shirakawa, T., Terao, S., Kaneko, N., Suganuma, K., Watanabe, M., Matsubara, T., Seto, R., Matsumoto, J., Kawakami, M., Yamamori, M., Nakamura, T., Yagami, T., Sakaeda, T., Fujisawa, M., Nishimura, O., and Okumura, K. (2008) Quantitative proteomic analysis to discover potential diagnostic markers and therapeutic targets in human renal cell carcinoma. Proteomics 8, 3194-3203
21. Perroud, B., Ishimaru, T., Borowsky, A. D., and Weiss, R. H. (2009) Grade-dependent proteomics characterization of kidney cancer. Mol. Cell. Proteomics 8, 971-985
22. Thoenes, W., Störkel, S., and Rumpelt, H. J. (1986) Histopathology and classification of renal cell tumors (adenomas, oncocytomas and carcinomas). The basic cytological and histopathological elements and their use for diagnostics. Pathol. Res. Pract. 181, 125-143
23. Störkel, S., and van den Berg, E. (1995) Morphological classification of renal cancer. World J. Urol. 13, 153-158
24. Störkel, S., Thoenes, W., Jacobi, G. H., and Lippold, R. (1989) Prognostic parameters in renal cell carcinoma - a new approach. Eur. Urol. 16, 416-422
25. Lichtenfels, R., Kellner, R., Atkins, D., Bukur, J., Ackermann, A., Beck, J., Brenner, W., Melchior, S., and Seliger, B. (2003) Identification of metabolic enzymes in renal cell carcinoma utilizing PROTEOMEX analyses. Biochim. Biophys. Acta 1646, 21-31
26. Lichtenfels, R., Kellner, R., Bukur, J., Beck, J., Brenner, W., Ackermann, A., and Seliger, B. (2002) Heat shock protein expression and anti-heat shock protein reactivity in renal cell carcinoma. Proteomics 2, 561-570
27. Atkins, D., Ferrone, S., Schmahl, G. E., Störkel, S., and Seliger, B. (2004) Down-regulation of HLA class I antigen processing molecules: an immune escape mechanism of renal cell carcinoma? J. Urol. 171, 885-889
28. Seliger, B., Lichtenfels, R., Atkins, D., Bukur, J., Haider, T., Kersten, M., Harder, A., Ackermann, A., Malenica, B., Brenner, W., Zobawa, M., and Lottspeich, F. (2005) Identification of fatty acid binding proteins as markers associated with the initiation and/or progression of renal cell carcinoma. Proteomics 5, 2631-2640
29. Görg, A., Boguth, G., Obermaier, C., and Weiss, W. (1998) Two-dimensional electrophoresis of proteins in an immobilized pH 4-12 gradient. Electrophoresis 19, 1516-1519
30. Recktenwald, C. V., Kellner, R., Lichtenfels, R., and Seliger, B. (2008) Altered detoxification status and increased resistance to oxidative stress by K-ras transformation. Cancer Res. 68, 10086-10093
31. Machka, C., Kersten, M., Zobawa, M., Harder, A., Horsch, M., Halder, T., Lottspeich, F., Hrabé de Angelis, M., and Beckers, J. (2005) Identification of Dll1 (Delta1) target genes during mouse embryogenesis using differential expression profiling. Gene Expr. Patterns 6, 94-101
32. Seliger, B., and Kellner, R. (2002) Design of proteome-based studies in combination with serology for the identification of biomarkers and novel targets. Proteomics 2, 1641-1651
33. Gygi, S. P., Rist, B., Gerber, S. A., Turecek, F., Gelb, M. H., and Aebersold, R. (1999) Quantitative analysis of complex protein mixtures using isotope-coded affinity tags. Nat. Biotechnol. 17, 994-999
34. Banks, R. E., Craven, R. A., Hamden, P. A., and Selby, P. J. (2003) Use of a sensitive EnVision +-based detection system for Western blotting: avoidance of streptavidin binding to endogenous biotin and biotin-containing proteins in kidney and other tissues. Proteomics 3, 558-561
35. Seliger, B., Menig, M., Lichtenfels, R., Atkins, D., Bukur, J., Haider, T. M., Kersten, M., Harder, A., Ackermann, A., Beck, J., Muehlenweg, B., Brenner, W., Melchior, S., Kellner, R., and Lottspeich, F. (2003) Identification of markers for the selection of patients undergoing renal cell carcinoma-specific immunotherapy. Proteomics 3, 979-990
36. Craven, R. A., Hanrahan, S., Totty, N., Hamden, P., Stanley, A. J., Maher, E. R., Harris, A. L., Trimble, W. S., Selby, P. J., and Banks, R. E. (2006) Proteomic identification of a role for the von Hippel Lindau tumour suppressor in changes in the expression of mitochondrial proteins and septin 2 in renal cell carcinoma. Proteomics 6, 3880-3893
37. Sarto, C., Valsecchi, C., Magni, F., Tremolada, L., Arizzi, C., Cordani, N., Casellato, S., Dora, G., Favini, P., Perego, R. A., Raimondo, F., Ferrero, S., Mocarelli, P., and Galli-Kienle, M. (2004) Expression of heat shock protein 27 in human renal cell carcinoma. Proteomics 4, 2252-2260
38. Sarto, C., Marocchi, A., Sanchez, J. C., Giannone, D., Frutiger, S., Golaz, O., Wilkins, M. R., Dora, G., Cappellano, F., Hughes, G., Hochstrasser, D. F., and Mocarelli, P. (1997) Renal cell carcinoma and normal kidney protein expression. Electrophoresis 18, 599-604
39. Shi, T., Dong, F., Liou, L. S., Duan, Z. H., Novick, A. C., and DiDonato, J. A. (2004) Differential protein profiling in renal-cell carcinoma. Mol. Carcinog. 40, 47-61
40. Fountoulakis, M. (2001) Proteomics: current technologies and applications in neurological disorders and toxicology. Amino Acids 21, 363-381
41. Seliger, B., Dressler, S. P., Wang, E., Kellner, R., Recktenwald, C. V., Lottspeich, F., Marincola, F. M., Baumgärtner, M., Atkins, D., and Lichtenfels, R. (2009) Combined analysis of transcriptome and proteome data as a tool for the identification of candidate biomarkers in renal cell carcinoma. Proteomics 9, 1567-1581
42. 2+ disturbances, and cell death in renal epithelial cells. J. Biol. Chem. 272, 21751-21759
43. Bellido, T., Huening, M., Raval-Pandya, M., Manolagas, S. C., and Christakos, S. (2000) Calbindin-D28k is expressed in osteoblastic cells and suppresses their apoptosis by inhibiting caspase-3 activity. J. Biol. Chem. 275, 26328-26332
44. Christakos, S., and Liu, Y. (2004) Biological actions and mechanism of action of calbindin in the process of apoptosis. J. Steroid Biochem. Mol. Biol. 89-90, 401-404
45. Sergeev, I. N. (2005) Calcium signaling in cancer and vitamin D. J. Steroid Biochem. Mol. Biol. 97, 145-151
46. Landriscina, M., Altamura, S. A., Roca, L., Gigante, M., Piscazzi, A., Cavalcanti, E., Costantino, E., Barone, C., Cignarelli, M., Gesualdo, L., and Ranieri, E. (2008) Reverse transcriptase inhibitors induce cell differentiation and enhance the immunogenic phenotype in human renal clear-cell carcinoma. Int. J. Cancer 122, 2842-2850
47. Martignoni, G., Pea, M., Chilosi, M., Brunelli, M., Scarpa, A., Colato, C., Tardanico, R., Zamboni, G., and Bonetti, F. (2001) Parvalbumin is constantly expressed in chromophobe renal carcinoma. Mod. Pathol. 14, 760-767
48. Kim, H. L., Seligson, D., Liu, X., Janzen, N., Bui, M. H., Yu, H., Shi, T., Figlin, R. A., Horvath, S., and Belldegrun, A. S. (2004) Using protein expressions to predict survival in clear cell renal carcinoma. Clin. Cancer Res. 10, 5464-5471
49. Visapää, H., Bui, M., Huang, Y., Seligson, D., Tsai, H., Pantuck, A., Figlin, R., Rao, J. Y., Belldegrun, A., Horvath, S., and Palotie, A. (2003) Correlation of Ki-67 and gelsolin expression to clinical outcome in renal clear cell carcinoma. Urology 61, 845-850
50. Osman, I., Bajorin, D. F., Sun, T. T., Zhong, H., Douglas, D., Scattergood, J., Zheng, R., Han, M., Marshall, K. W., and Liew, C. C. (2006) Novel blood biomarkers of human urinary bladder cancer. Clin. Cancer Res. 12, 3374-3380
51. Storch, J., and Thumser, A. E. (2000) The fatty acid transport function of fatty acid-binding proteins. Biochim. Biophys. Acta 1486, 28-44
52. Hashimoto, T., Kusakabe, T., Sugino, T., Fukuda, T., Watanabe, K., Sato, Y., Nashimoto, A., Honma, K., Kimura, H., Fujii, H., and Suzuki, T. (2004) Expression of heart-type fatty acid-binding protein in human gastric carcinoma and its association with tumor aggressiveness, metastasis and poor prognosis. Pathobiology 71, 267-273
53. Kimura, H., Fujii, H., Suzuki, S., Ono, T., Arakawa, M., and Gejyo, F. (1999) Lipid-binding proteins in rat and human kidney. Kidney Int. Suppl. 71, S159-S162